(Q48874157)

English

Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

object named as

Jayne E Bailey

1

0 references

object named as

David J Nutt

9

0 references

Colin T Dourish

object named as

Colin T Dourish

7

0 references

author name string

Andreas Papadopoulos

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

Alison Diaper

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

Suzanne Phillips

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

Me Schmidt

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

P van der Ark

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

Gerard R Dawson

8

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

language of work or name

0 references

publication date

9 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

25

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

1199-1206

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Validating the inhalation of 7.5% CO(2) in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD).

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

CRH-sub-1 receptor antagonists for the treatment of depression and anxiety

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Acute carbon dioxide exposure in healthy adults: evaluation of a novel means of investigating the stress response.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Role of corticotropin releasing factor in anxiety disorders: a translational research perspective

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Development of CRF1 receptor antagonists as antidepressants and anxiolytics: progress to date

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881111400650

21 January 2018

Identifiers

10.1177/0269881111400650

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21555331

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48874157&oldid=1091892836"